Video

Dr Renee Arnold Explains the Benefit of Pharmacoeconomic Analysis

With the high cost of medications, pharmacoeconomic analysis to determine the additional benefit being derived from additional cost is important, explained Renee JG Arnold, PharmD, RPh, practice lead for health economics and outcomes research at Quorum Consulting, Inc.

With the high cost of medications, pharmacoeconomic analysis to determine the additional benefit being derived from additional cost is important, explained Renee JG Arnold, PharmD, RPh, practice lead for health economics and outcomes research at Quorum Consulting, Inc

Transcript (slightly modified)

What is the importance of pharmacoeconomic analysis in healthcare decision making?

Well, pharmacoeconomic analysis is basically what somebody would consider cost effectiveness analysis. And it really helps to determine what is the additional benefit that you’re deriving for typically an additional cost, and especially with today’s pretty expensive medications it’s really important to determine if something is cost effective.

Can you provide an overview of the different types of evaluation techniques?

Right, so they really only differ in their denominator. Cost effectiveness or pharmacoeconomic analysis is basically cost divided by effectiveness. So if you do a cost minimization analysis you’re looking for equally effective agents or alternatives and, in which case, the denominator goes away basically. In a cost benefit analysis, the denominator is in monetary units so it’s dollars. Cost effectiveness analysis is usually some kind of metric like life years saved or myocardial infarction avoided. And cost utility analysis is a subgroup of cost effectiveness analysis in that it uses a quality of life adjustment to that effectiveness metric.

Related Videos
Marla Black Morgan, MD, Phoebe Neurology Associates
Toby Maher, MD, PhD, professor of clinical medicine, Keck School of Medicine at USC
Nini Wu, MD, Navista
Matthew Viggiano, MD, internal medicine resident, Temple University Hospital
Krunal Patel, MD, pulmonary and critical care fellow, Temple University Hospital
M. Bradley Drummond, MD, MHS, professor of medicine, University of North Carolina at Chapel Hill
Sanjay Ramakrishnan, MD, senior lecturer, University of Western Australia
Michael Goulet, DO, pulmonary and critical care fellow, Temple University Hospital
Tom Belmon, CAP, GPBCH
Tom Belmont
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo